Reuptake inhibitor

From Wikipedia, the free encyclopedia

This article does not cite any references or sources. (April 2008) Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed.

A reuptake inhibitor blocks the reuptake of neurotransmitters from the synaptic cleft, increasing its levels. A series of commonly prescribed antidepressant medications rely on reuptake inhibition. For example, the selective serotonin reuptake inhibitor (SSRI) class of medications block the reuptake of serotonin and thereby increases the level of serotonin in the brain. Serotonin is a neurotransmitter. It is produced by cells in the brain and is used by nerves to communicate with one another. A nerve releases the serotonin that it has produced into the space surrounding it. The serotonin either travels across that space and attaches to receptors on the surface of nearby neuron or it attaches to receptors on the surface of the neuron that produced it, to be taken up by the neuron, recycled, and released again. This process is referred to as reuptake. A balance is reached for serotonin between attachment to the nearby neurons and reuptake. When a neuron's receptor cells are blocked by neural inhibitors, all of it is forced to be released into the bloodstream, increasing the levels. Popular SSRIs like sertraline and fluoxetine do this, causing the serotonin to be collected by the receptor cells and overall increasing the levels of the neurotransmitter.